1. Pro-innovation bias. This bias, first described by the innovation guru Everett Rogers in the 1960s, says that anything new is inherently better than anything already in use. 3 People are classified in the value-laden terms 'innovators' (the best sort of person to be) followed by 'early adopters', 'early majority', 'late majority', and 'laggards'. Who in their right mind would be a laggard? 4 This is what Dourish and Bell call the 'proximate future': a time, just around the corner, of 'calm computing' when all technologies will be plug-and-play and glitch-free. 5 3. Bells and whistles bias. This bias assumes that the more functions a technology offers, the better it will work. If you have ever tried to make the case to a salesperson that you want a mobile phone for the purposes of making phone calls, not to track your global positioning, take photographs, or check your email, you will know the counter-argument to this.
4. Connectivity bias. This assumes that the more technologies and systems to which a new technology can connect, the more useful it will be. The computer system that sits in splendid isolation, processing a parochial dataset for a local team is seen as so 20th century compared to one that links to a national or, better, international data archive. Yet as those of us who regularly have to link our practice record system to the N3 Spine know to our cost, local systems work faster and more reliably the fewer external connections they make.
5. Human substitution bias. This bias assumes that whatever the task, a technology is as good as, or better than, a human. When we are sick, lonely, or distressed, we crave company. If you do not believe that a whole research industry is now emerging oriented to developing 'social presence robots' that will substitute for real, flesh-and-blood humans in these very situations, check out the studies emerging in the robotics journals. 6, 7 If these biases conjure up the kind of Brave New World in which you would prefer not to live, perhaps it's time for a programme of research and social protest to parallel what Godlee and Goldacre have been spearheading in relation to pharmaceuticals.
